Zeta Corporation

Zeta Corporation is an ISO 13485:2016 and FDA-registered biomedical manufacturer specializing in precision recombinant in vitro diagnostic (IVD) antibodies for immunohistochemistry (IHC) applications. The company develops and distributes a portfolio of over 400 tumor and tissue-specific IVD recombinant antibodies designed for anatomic pathology laboratories. Zeta's product lines include MonoMAb™ monospecific mouse monoclonal antibodies and RAbMono™ rabbit monoclonal antibodies, both engineered for high specificity, sensitivity, and reproducibility on formalin-fixed, paraffin-embedded (FFPE) tissue sections. All antibodies are rigorously validated and target-verified by pathologists to ensure consistent, reliable diagnostic results. With over 75 years of collective scientific expertise, Zeta manufactures antibodies using recombinant production methods for rapid, reliable manufacturing and distributes directly in the United States and through trusted partners to over 50 countries worldwide.